Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-07-27
DOI
10.1093/eurheartj/ehab533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
- (2020) Mariusz Tomaniak et al. Clinical Research in Cardiology
- Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
- (2020) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
- (2020) Mauro Chiarito et al. LANCET
- Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
- (2020) Byeong-Keuk Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
- (2020) Davide Cao et al. EUROPEAN HEART JOURNAL
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Oxidative stress in chronic kidney disease
- (2018) Kristien Daenen et al. PEDIATRIC NEPHROLOGY
- P2Y 12 -ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes
- (2018) Laurent Bonello et al. CIRCULATION
- Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
- (2017) G. Ocak et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease
- (2017) Nisha Bansal et al. JAMA Cardiology
- Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
- (2016) Usman Baber et al. AMERICAN HEART JOURNAL
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Risk of Major Hemorrhage with CKD
- (2016) A. O. Molnar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry
- (2015) U. Baber et al. Circulation-Cardiovascular Interventions
- Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
- (2015) Philippe Généreux et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
- (2015) Kunihiro Matsushita et al. Lancet Diabetes & Endocrinology
- The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents
- (2014) Giulio G. Stefanini et al. PLoS One
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Haemostasis in chronic kidney disease
- (2013) Jens Lutz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Antithrombotic Therapy in Patients With Chronic Kidney Disease
- (2012) Davide Capodanno et al. CIRCULATION
- Third Universal Definition of Myocardial Infarction
- (2012) Kristian Thygesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coronary Plaque Composition, Morphology, and Outcomes in Patients With and Without Chronic Kidney Disease Presenting With Acute Coronary Syndromes
- (2012) Usman Baber et al. JACC-Cardiovascular Imaging
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
- (2011) Olivier Morel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
- (2010) Stefan James et al. CIRCULATION
- In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
- (2010) P. C. J. ARMSTRONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)
- (2009) Arijit Dasgupta et al. AMERICAN JOURNAL OF CARDIOLOGY
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
- (2009) R. Mehran et al. EUROPEAN HEART JOURNAL
- The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial
- (2008) Patricia J.M. Best et al. AMERICAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More